Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
guardian.co.uk » The Guardian World News - 9 hours ago
When Terri was diagnosed with cancer, Lionel Shriver was doting – at first. But as her condition worsened, there always seemed to be a reason not to call… I met Terri in the early 1980s at an arts camp in Connecticut …
Also tagged: health, relationships, books, features, culture, the guardian, bereavement
guardian.co.uk » Books news, reviews and author interviews | guardian.co.uk - 11 hours ago
When Terri was diagnosed with cancer, Lionel Shriver was doting – at first. But as her condition worsened, there always seemed to be a reason not to call… I met Terri in the early 1980s at an arts camp in Connecticut …
Also tagged: health, relationships, books, features, culture, the guardian, bereavement
cnn.com » Brainstorm Tech: Technology blogs, news and analysis from Fortune Magazine » Apple 2.0 - 11 hours ago
A year later, he talks for the first time about the operation that saved his life. "I was lucky," said Steve Jobs in brief remarks Friday in support of a new California organ donation bill. "Because many others died …
Also tagged: apple, aapl, steve jobs, organ transplant, liver transplant, apple 2 0, scharzenegger
fiercebioresearcher.com » News - 13 hours ago
This week, the New York Times is tracing the Phase I testing of a novel melanoma drug being developed by Plexxikon and Roche. The paper says to chronicle the three years of PLX4032 testing "is to ride a roller coaster …
fiercebioresearcher.com » News - 13 hours ago
A new molecule that seeks out and labels cancer cells could help guide surgeons to hidden pockets of disease--and one day could allow for more complete tumor removal. The label was developed by researchers at the …
Also tagged: biomarkers
xconomy.com » Xconomy Life Sciences Feed - 24 hours ago
Seattle-based Cell Therapeutics (NASDAQ: CTIC) is getting ready, one more time, for its make-or-break moment. The big East Coast snowstorm of mid-February postponed this day of reckoning a few weeks, so the company is …
Also tagged: drugs, seattle, biotech, fda, non hodgkin s lymphoma, cell therapeutics, life sciences, pixantrone, james bianco, national blog main, seattle blog main
rnainews.com » RNAi News from GenomeWeb - Mar 19, 2010
The ongoing trial is expected to help lay the groundwork for a follow-on cancer therapy that will also incorporate the company's novel RNAi approach, and is expected to enter phase I testing around the third quarter.
Also tagged: clinic, rnai, gradalis, shrna, john nemunaitis
cba-news.com » GenomeWeb Daily News - Mar 19, 2010
Prometheus will develop diagnostic pathway technologies for Bayer Schering Pharma's cancer drug candidates under a deal which could bring in up to $160 million to Prometheus.
Also tagged: licensing agreement, pharmacogenomics, bayer schering pharma, prometheus laboratories, dxpgx, pathway maps
bioinform.com » BioInform from GenomeWeb News - Mar 19, 2010
Eureka Genomics has a two-pronged business model that involves sequencing services and internal discovery projects to identify novel disease-associated microorganisms. Underlying this hybrid model is a portfolio of …
Also tagged: services, bioinformatics, informatics, sequencing, eureka genomics, abrf
xconomy.com » Xconomy - Mar 19, 2010
The best reporters are always gathering string, as we like to say in the journalism trade. It means we gather lots of facts and observations in our notebooks, which might not be news at first glance, but can become …
Also tagged: seattle, biotech, startups, pfizer, autoimmune, bristol myers squibb, hepatitis c, rheumatoid arthritis, zymogenetics, il 6, age related macular degeneration, rna interference, national blog main, seattle blog main, tekmira pharmaceuticals, alder biopharmaceuticals, celator pharmaceuticals, acucela, ryo kubota, european league against rheumatism, hemaquest pharmaceuticals, ron berenson, jennifer hamilton, nomura phase4 ventures